DigestRedComo funciona
Red
/
Empresas
Th
No verificado

Thetis Pharmaceuticals LLC

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud

3 Comunicados de prensa

Ver todos los comunicados de prensa
05/05/2025
Eventos
Industria
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Oncología
Thetis Pharmaceuticals Presents New Preclinical and Clinical Data forTP-317 at DDW 2025
Fuente
Thetis Pharmaceuticals LLC
Editor
Business Wire
1.00
0
19/02/2025
Eventos
Industria
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Thetis Pharmaceuticals Presents New Preclinical and Clinical Data for TP-317 at ECCO 2025
Fuente
Thetis Pharmaceuticals LLC
Editor
Business Wire
1.00
0
09/01/2025
Industria
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Thetis Pharmaceuticals Secures an Additional $8.975 Million in Program-Related Investment Funds from the Helmsley Charitable Trust to Advance TP-317, an Oral BLT1 Agonist, into a Phase 1b Trial in Ulcerative Colitis Patients
Fuente
Thetis Pharmaceuticals LLC
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0